Related Experiment Videos
Intestinal perforation secondary to paclitaxel
1Department of Obstetrics and Gynecology, University MacDonald Womens Hospital, Case Western Reserve, University, Cleveland, Ohio 44106, USA.
Gynecologic Oncology
|May 1, 1995
Summary
Paclitaxel therapy can cause colonic perforation, a serious side effect leading to a 57% mortality rate. Medical professionals should suspect this complication in patients with abdominal pain after paclitaxel treatment.
Area of Science:
- Oncology
- Gastroenterology
- Pharmacology
Background:
- Paclitaxel is a widely used chemotherapy agent for various cancers.
- Gastrointestinal complications are known side effects of chemotherapy.
- Colonic perforation is a rare but severe adverse event.
Observation:
- Three cases of colonic perforation following paclitaxel administration are presented.
- This complication is hypothesized to be a direct cytotoxic effect of paclitaxel on the gastrointestinal epithelium, inducing mitotic arrest.
- A total of eleven cases have been identified in the literature.
Findings:
- Colonic perforation following paclitaxel therapy is a serious complication.
- The mortality rate associated with this adverse event is high, at 57%.
- The true incidence may be underestimated, potentially misattributed to disease progression.
Implications:
- A high index of suspicion is warranted for patients presenting with abdominal pain post-paclitaxel therapy.
- Early recognition and management are crucial due to the high mortality.
- Further research is needed to determine the exact incidence and underlying mechanisms.